bims-conane Biomed News
on Congenital anemias
Issue of 2026–03–22
one paper selected by
João Conrado Khouri dos Santos, Universidade de São Paulo



  1. J Perinatol. 2026 Mar 16.
       BACKGROUND: Neonatal jaundice is most commonly caused by blood group incompatibility but may also result from hereditary elliptocytosis (HE) associated with heterozygous SPTB mutations.
    METHODS: A retrospective descriptive study was conducted among 1,584 neonates presenting with jaundice over a 3-year period.
    RESULTS: Seventy-six neonates (4.8%) were diagnosed with HE, all carrying heterozygous SPTB mutations (Providence variant, n = 67; Buffalo variant, n = 9). Five had coexisting hemoglobinopathies. Early-onset jaundice occurred in 71 patients, with a median onset of 38 h. Peak total bilirubin levels ranged from 12.2 to 22.3 mg/dL. Most neonates required single phototherapy; seven required double phototherapy, and none underwent exchange transfusion. Anemia developed in 23 patients, of whom 17 required red cell transfusion.
    CONCLUSION: HE is an under-recognized cause of early-onset neonatal jaundice and anemia. Despite early hyperbilirubinemia, most neonates have a benign clinical course with minimal long-term complications and infrequent need for transfusion.
    DOI:  https://doi.org/10.1038/s41372-026-02621-0